Antiretroviral therapy for HIV infection in infants and children: Towards universal access
Executive summary of recommendations. Preliminary version for program planning
Tremendous progress has been made over the past few years in diagnosing and treating infants and children with human immunodeficiency virus (HIV) infection. However, much remains to be done to effectively scale up and sustain prevention efforts and treatment services for all in need. The most efficient and cost-effective way to tackle paediatric HIV globally is to reduce mother-to-child transmission (MTCT).
The WHO guidelines Antiretroviral therapy for HIV infection in infants and children are based on a public
health approach to HIV care. The update of these guidelines’ is harmonized with the treatment guidelines
adopted for adults, pregnant women, and prevention of mother-to-child transmission (PMTCT).
The present guidelines are part of WHO’s commitment to achieve universal access to the prevention, care and treatment of HIV infection in infants and children.